LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-10-15
Case ID: NM_000314.8_c.1012_1016del_20261015_214259
Framework: ACMG/AMP 2015
Variant classification summary

NM_000314.8:c.1012_1016del

PTEN  · NP_000305.3:p.(Ser338LysfsTer3)  · NM_000314.8
GRCh37: chr10:89720860 TTCTCC>T  ·  GRCh38: chr10:87961103 TTCTCC>T
Gene: PTEN Transcript: NM_000314.8
Final call
Likely Pathogenic
PVS1 very strong PM2 supporting
All criteria require review: For research and educational purposes only.
Gene
PTEN
Transcript
NM_000314.8
Protein
NP_000305.3:p.(Ser338LysfsTer3)
gnomAD AF
ClinVar
OncoKB
Likely Oncogenic
Interpretation summary
Generated evidence synthesis
1
Likely Pathogenic: PVS1 (very strong) reflects a truncating frameshift upstream of the PTEN VCEP NMD threshold.
2
Likely Pathogenic: PM2 (supporting) reflects absence from gnomAD v2.1 and v4.1.
Final determination: Under Rule20 of the ClinGen PTEN Expert Panel Version 3.2 framework, one very strong pathogenic criterion plus two moderate criteria or one supporting criterion yields Likely Pathogenic; here PVS1 very strong plus PM2 supporting is the matched combination.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 Met Met at very strong: the frameshift truncates PTEN at p.Ser338, before the VCEP p.D375 (c.1121) NMD threshold in transcript NM_000314.8.
cspec vcep_pvs1_decisiontree_pten
PS1 N/A Not applicable: c.1012_1016del is a frameshift, p.(S338Kfs*3), rather than a missense amino-acid substitution required for this PS1 comparison.
cspec
PS2 Not assessed Not assessed: no proband diagnosis, parental testing, maternity/paternity confirmation, or family-history documentation is available for this variant.
cspec
PS3 N/A Not applicable: the PTEN VCEP functional rule covers high-confidence missense assay entries, whereas this variant is a frameshift absent under all three searched notations.
cspec vcep_mmc2 PMID:11237521 PMID:17218262
PS4 Not assessed Not assessed: no variant-specific case-control enrichment or phenotype-specificity score is available for comparison with the PTEN PS4 thresholds.
cspec
PM1 Not met Not met: the variant begins at residue 338, outside the PTEN VCEP PM1 catalytic-motif intervals 90–94, 123–130, and 166–168.
cspec PMID:11237521
PM2 Met Met, Supporting: the variant is absent from gnomAD v2.1 and v4.1, meeting the PTEN PM2 threshold below 0.00001 (0.001%).
cspec gnomad_v2 gnomad_v4
PM3 N/A Not applicable: the PTEN VCEP specification explicitly designates PM3 as not applicable for this autosomal-dominant disorder.
cspec
PM4 N/A Not applicable: the variant is a frameshift with a premature stop, whereas PTEN PM4 covers in-frame length changes or stop-loss extensions.
cspec
PM5 N/A Not applicable: PM5 requires a missense change at a residue with a pathogenic or likely pathogenic alternate missense change, whereas this variant is a frameshift.
cspec
PM6 Not assessed Not assessed: no assumed de novo observation, parental results, proband diagnosis, family history, or independent occurrence count is documented.
cspec
PP1 Not assessed Not assessed: no affected relatives, segregation results, phase information, or meiosis count is documented for this variant.
cspec
PP2 N/A Not applicable: the PTEN VCEP PP2 rule is missense-specific, while this variant is the frameshift p.(S338Kfs*3).
cspec
PP3 N/A Not applicable: the variant is a frameshift, p.(S338Kfs*3), outside PP3's calibrated missense and splice-impact scope.
cspec
PP4 N/A Not applicable: the PTEN VCEP incorporates phenotype specificity into PS4 and marks PP4 as not applicable.
cspec
PP5 N/A Not applicable: the PTEN VCEP excludes PP5, and ClinVar has no exact-variant expert-panel Pathogenic or Likely pathogenic classification.
cspec clinvar
BA1 Not met Not met: gnomAD v2.1 and v4.1 report the variant absent, not a filtering allele frequency greater than 0.00056 (0.056%).
cspec gnomad_v2 gnomad_v4
BS1 Not met Not met: gnomAD v2.1 and v4.1 report absence, with no allele frequency in the PTEN BS1 range of 0.0000043 to 0.00056.
cspec gnomad_v2 gnomad_v4
BS2 Not met Not met: the variant is absent from gnomAD v2.1 and v4.1, with no reported homozygous healthy individual.
cspec gnomad_v2 gnomad_v4
BS3 N/A Not applicable: the PTEN VCEP benign functional rules require applicable missense or splicing assay evidence, but this frameshift has no exact entry under the searched variant notations.
cspec vcep_mmc2 PMID:11237521 PMID:17218262
BS4 Not assessed Not assessed: no affected family members or variant-testing results demonstrate non-segregation in one or more families.
cspec
BP1 N/A Not applicable: the PTEN VCEP explicitly marks BP1 as not applicable, and this case variant is a truncating frameshift rather than a missense variant.
cspec
BP2 Not assessed Not assessed: no second pathogenic PTEN variant or cis/trans phase observation is available to meet the VCEP BP2 rule.
cspec
BP3 N/A Not applicable: the PTEN VCEP marks BP3 as not applicable, and this variant is a truncating frameshift rather than a repeat-region in-frame deletion.
cspec
BP4 N/A Not applicable: the variant is a frameshift, p.(S338Kfs*3), outside BP4's calibrated missense and splice-impact scope.
cspec
BP5 Not assessed Not assessed: no two qualifying cases with a highly penetrant alternate diagnosis and non-overlapping PTEN histories are documented.
cspec
BP6 N/A Not applicable: the PTEN VCEP excludes BP6, and ClinVar has no exact-variant expert-panel Benign or Likely benign classification.
cspec clinvar
BP7 N/A Not applicable: the variant is a frameshift, p.(S338Kfs*3), not the synonymous variant required for BP7.
cspec
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.